Analysed MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) News Sources
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
30-04-2026
yahoo.com
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
12-05-2026
yahoo.com
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
19-05-2026
yahoo.com
Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet
22-05-2026
yahoo.com
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
28-05-2026
yahoo.com
Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
03-06-2026
yahoo.com
What is the current price of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The current price of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is $0.33.
MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) since the previous trading day is $0.01553.
MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) since the previous trading day is 4.9385%.
What is the most recent average sentiment score for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The most recent average sentiment score for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)?
The most recent sentiment for MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS) is .
SEC-8K** Filing Available For MEDICENNA THERAPEUTICS CORP (MDNAF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.